Table 9.
Therapy/prophylaxis | Drug | Therapeutic regimen |
---|---|---|
Acute therapy | ||
Induction therapy (treat at least 2 weeks before switch/de-escalation) | ||
First choice | Amphotericin B + flucytosine | 1 × 0.7 mg/kg/day i.v. or liposomal Amphotericin B (AmBisome®) 1 × 3–4 mg/kg/day i.v. + Ancotil® 4 × 25 mg/kg/day i.v./p.o. or 100 mg/day distributed in four separate doses |
De-escalation with good response (at least after 2 weeks) | ||
First choice | Fluconazole | 1 × 400 mg p.o. (For at least 8 more weeks) |
Alternatives | Itraconazole | 2 × 200 mg p.o. (For at least 8 more weeks) |
Primary prophylaxis | Not recommended in Germany | |
Secondary prophylaxis | Fluconazole | 200 mg/day p.o. |
Discontinuation is possible when CD4 T-cell count is >100 cells /μl and HIV-RNA below detection limit for a period of 6 months |
aDaily doses, unless specified otherwise